Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Mezei, A. Cohen, J. Renwick, M. J. Atwell, J. Portnoy, A.

Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review

  • All age groups
  • Low and Middle Income Countries
  • RSV (Respiratory syncytial virus)
  • Modeling
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Soodejani, M. T. Basti, M. Tabatabaei, S. M. Rajabkhah, K.

Measles, mumps, and rubella (MMR) vaccine and COVID-19: A systematic review

  • All age groups
  • Measles
  • Mumps
  • Rubella
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Hodgkinson, B. Wang, T. Byrnes, J. Scuffham, P.

Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review

  • All age groups
  • Varicella
  • Economic aspects
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Molica, S. Giannarelli, D. Montserrat, E.

mRNA COVID-19 vaccines in patients with CLL: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Alamoodi, A. H. Zaidan, B. B. Al-Masawa, M. Taresh, S. M. Noman, S. Ahmaro, I. Y. Y. Garfan, S. Chen, J. Ahmed, M. A. Zaidan, A. A. Albahri, O. S. Aickelin, U. Thamir, N. N. Fadhil, J. A. Salahaldin, A.

Multi-perspectives systematic review on the applications of sentiment analysis for vaccine hesitancy

  • All age groups
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Donadel, M. Panero, M. S. Ametewee, L. Shefer, A. M.

National decision-making for the introduction of new vaccines: A systematic review, 2010–2020

  • All age groups
  • Economic aspects
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Chen, J. Cai, Y. Chen, Y. Williams, A. P. Gao, Y. Zeng, J.

Nervous and Muscular Adverse Events after COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Clinical Trials

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Shafiq, A. Salameh, M. A. Laswi, I. Mohammed, I. Mhaimeed, O. Mhaimeed, N. Mhaimeed, N. Paul, P. Mushannen, M. Elshafeey, A. Fares, A. Holroyd, S. Zakaria, D.

Neurological Immune Related Adverse Events Post-COVID-19 Vaccination: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Chen, X. Chen, Z. Azman, A. S. Sun, R. Lu, W. Zheng, N. Zhou, J. Wu, Q. Deng, X. Zhao, Z. Chen, X. Ge, S. Yang, J. Leung, D. T. Yu, H.

Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Wu, H. H. L. Kalra, P. A. Chinnadurai, R.

New-onset and relapsed kidney histopathology following covid-19 vaccination: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...